Bio-Rad Laboratories, Inc. (BIO.B) vs STERIS plc (STE)

Bio-Rad Laboratories, Inc. and STERIS plc are both Medical Devices companies. STERIS plc is the larger, with a market value of $20.4B against $10.3B — 2.0× the size. STERIS plc trades at the lower P/E: 25.4× against 43.8×. STERIS plc grew revenue faster over the last twelve months: 8.37% against 1.37%. STERIS plc has the higher net margin (13.3% vs 8.59%) and the higher return on invested capital (8.27% vs 0.49%). Across the 22 metrics below, STERIS plc leads on 15 and Bio-Rad Laboratories, Inc. on 7.

Valuation

Metric BIO.B STE Medical Devices median
P/E 43.83 25.45 22.18
P/S 3.77 3.38 2.70
P/B 1.36 2.82 2.46
Price to free cash flow 27.50 21.79 22.53
EV/EBITDA 176.08 13.35 11.78
EV/Sales 3.61 3.61 2.38
Earnings yield 2.28% 3.93% (8.22%)
Free cash flow yield 3.64% 4.59% (7.80%)

Profitability

Metric BIO.B STE Medical Devices median
Gross margin 51.90% 44.43% 56.01%
Operating margin 2.05% 18.91% (15.03%)
Net margin 8.59% 13.33% (20.40%)
Free cash flow margin 13.64% 15.50% (7.24%)
Return on equity 3.11% 11.35% (15.32%)
Return on assets 2.17% 7.62% (19.72%)
Return on invested capital 0.49% 8.27% (10.33%)

Growth

Metric BIO.B STE Medical Devices median
Revenue growth (TTM) 1.37% 8.37% 8.80%
EPS growth (last fiscal year) 142.61% 27.90% —
Revenue growth, 5-year CAGR 0.29% 13.82% 15.23%
Net income growth, 5-year CAGR (27.58%) 14.51% 0.00%

Health

Metric BIO.B STE Medical Devices median
Debt to equity 0.17 0.26 0.07
Current ratio 3.14 1.91 2.50
Net debt to EBITDA (7.15) 0.94 0.49

Dividend

Metric BIO.B STE Medical Devices median
Dividend yield — 0.92% 0.94%
Payout ratio 0.00 1.55 0.00

Size

Metric BIO.B STE Medical Devices median
Market cap 10.33b 20.36b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack